DelphX Capital Markets Inc. has started a non-brokered private placement offering up to 7 million units at C$0.01 each, aiming to raise approximately C$70,000. Each unit includes one common share and one warrant to buy an additional share at C$0.06 within two years. The funds will support working capital and corporate overhead, with up to 10% allocated to investor relations. The offering requires TSX Venture Exchange approval and is expected to close by October 26, 2026. Additionally, DelphX plans to end its OTC Markets US quotation, focusing on its primary TSX Venture Exchange listing.
DelphX Capital Markets Inc.'s private placement offering aims to raise approximately C$70,000. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 20, 2026 04:51 WIB: out of 142 priced US Financials stocks, 41 rose and 100 fell. Notable movers include GEMI at USD 3.14 with a 1-day change of -12.04% and a typical hold time on Pluang of 15 days, FIGR at USD 25.75 with a 1-day change of -5.09% and 100% buy order activity, and PSEC at USD 1.52 with a 1-day change of -5.00% and 100% buy order activity.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
